COMBRESTATIN A4

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H20O5
Molecular Weight	316.3484
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure of COMBRESTATIN A4

Structure Search

SMILES

COC1=CC(\C=C/C2=CC(O)=C(OC)C=C2)=CC(OC)=C1OC

InChI

InChIKey=HVXBOLULGPECHP-WAYWQWQTSA-N

InChI=1S/C18H20O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h5-11,19H,1-4H3/b6-5-

HIDE SMILES / InChI

Molecular Formula	C18H20O5
Molecular Weight	316.3484
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	1
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 18:39:56 UTC 2023` Edited by `admin` on `Sat Dec 16 18:39:56 UTC 2023`
Record UNII	16U6OP69RQ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

COMBRESTATIN A4

Common Name

English

COMBRETASTATIN A-4 [MI]

Common Name

English

COMBRETASTATIN 4

Common Name

English

2'-DEOXYCOMBRETASTATIN A1

Common Name

English

PHENOL, 2-METHOXY-5-(2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-, (Z)-

Common Name

English

CA4

Code

English

Combretastatin A4 [WHO-DD]

Common Name

English

COMBRETASTATIN A4

Common Name

English

NSC-613729

Code

English

NSC-817373

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

217805

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

EU-Orphan Drug

EU/3/04/195

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

Code System Code Type Description

CAS

117048-59-6

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

EPA CompTox

DTXSID101025983

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

FDA UNII

16U6OP69RQ

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

WIKIPEDIA

Combretastatin A-4

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

NSC

817373

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

SMS_ID

100000089857

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

MERCK INDEX

m3747

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

Merck Index

DRUG BANK

DB14680

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

EVMPD

SUB26304

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

NCI_THESAURUS

C2711

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

NSC

613729

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

PUBCHEM

5351344

Created by admin on Sat Dec 16 18:39:57 UTC 2023 , Edited by admin on Sat Dec 16 18:39:57 UTC 2023

PRIMARY

Related Record Type Details


					82JB1524Q6

DERIVATIVE -> PARENT

Amount:

Related Record Type Details


					Y15Y23O7TV

2-METHOXY-5-((1Z)-2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-1,4-BENZENEDIOL

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:


					E4GJY8TZR6

2-METHOXY-5-((1E)-2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-1,4-BENZENEDIOL

METABOLITE -> PARENT

Comments:

IN VITRO


					444L3J211N

4-((1Z)-2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-1,2-BENZENEDIOL

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:


					I5590ES2QZ

PRODRUG -> METABOLITE ACTIVE

Amount:


					6U4RXK38M9

2,5-CYCLOHEXADIENE-1,4-DIONE, 2-METHOXY-5-((1E)-2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-

METABOLITE -> PARENT

Comments:

IN VITRO


					N64ZKX59NE

COMBRETASTATIN A3

METABOLITE -> PARENT

Comments:

IN VITRO


					T86N8IE0JH

2,5-CYCLOHEXADIENE-1,4-DIONE, 2-METHOXY-5-((1Z)-2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:


					PT7A64BA71

4-((1E)-2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-1,2-BENZENEDIOL

METABOLITE -> PARENT

Comments:

IN VITRO


					PB4S7WD65N

(E)-3',4-DIHYDROXY-3,4',5-TRIMETHOXY-STILBENE

METABOLITE -> PARENT

Comments:

IN VITRO

Related Record Type Details


					16U6OP69RQ

COMBRESTATIN A4

ACTIVE MOIETY

Amount: